These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 32823418)

  • 21. Tumor necrosis factor alpha blockade with infliximab for refractory uveitis and scleritis.
    Murphy CC; Ayliffe WH; Booth A; Makanjuola D; Andrews PA; Jayne D
    Ophthalmology; 2004 Feb; 111(2):352-6. PubMed ID: 15019389
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic ophthalmology. Necrotic scleritis and uveitis.
    Grahn BH; Cullen CL; Wolfer J
    Can Vet J; 1999 Sep; 40(9):679-80. PubMed ID: 10495915
    [No Abstract]   [Full Text] [Related]  

  • 23. Mycophenolate Mofetil Therapy in Refractory Inflammatory Eye Disease.
    Cuchacovich M; Solanes F; Perez C; Verdaguer JI; Verdaguer J; Castiglione E; Carpentier C; Traipe L; Villarroel F
    J Ocul Pharmacol Ther; 2016; 32(1):55-61. PubMed ID: 26562247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical profile of patients with posterior scleritis: A report from Eastern India.
    Kumar A; Ghose A; Biswas J; Majumder PD
    Indian J Ophthalmol; 2018 Aug; 66(8):1109-1112. PubMed ID: 30038152
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Postmarketing surveillance rates of uveitis and scleritis with bisphosphonates among a national veteran cohort.
    Fraunfelder FW; Winthrop K; Suhler E; Choi D; Fraunfelder FT
    Retina; 2009 Feb; 29(2):285-6; author reply 286-7. PubMed ID: 19202428
    [No Abstract]   [Full Text] [Related]  

  • 26. IgG4-related disease in the eye and ocular adnexa.
    Derzko-Dzulynsky L
    Curr Opin Ophthalmol; 2017 Nov; 28(6):617-622. PubMed ID: 28858963
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Posterior Scleritis: Analysis of Epidemiology, Clinical Factors, and Risk of Recurrence in a Cohort of 114 Patients.
    Lavric A; Gonzalez-Lopez JJ; Majumder PD; Bansal N; Biswas J; Pavesio C; Agrawal R
    Ocul Immunol Inflamm; 2016; 24(1):6-15. PubMed ID: 26134101
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pattern of Scleritis in an Egyptian Cohort.
    Abd El Latif E; Seleet MM; El Hennawi H; Abdulbadiea Rashed M; Elbarbary H; Sabry K; Abdelmonagy Ibrahim M
    Ocul Immunol Inflamm; 2019; 27(6):890-896. PubMed ID: 30412434
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical characteristics of a large cohort of patients with scleritis and episcleritis.
    Sainz de la Maza M; Molina N; Gonzalez-Gonzalez LA; Doctor PP; Tauber J; Foster CS
    Ophthalmology; 2012 Jan; 119(1):43-50. PubMed ID: 21963265
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Episcleritis and scleritis.
    White GE
    Optom Clin; 1991; 1(4):79-87. PubMed ID: 1799838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Posterior scleritis in children: clinical features and treatment.
    Cheung CM; Chee SP
    Ophthalmology; 2012 Jan; 119(1):59-65. PubMed ID: 22137553
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [MALT-type B-cell lymphoma masquerading as scleritis or posterior uveitis].
    Gaucher D; Bodaghi B; Charlotte F; Schneider C; Cassoux N; Lemaitre C; Leblond V; Rao N; LeHoang P
    J Fr Ophtalmol; 2005 Jan; 28(1):31-8. PubMed ID: 15767896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Correlates, Outcomes, and Predictors of Inflammatory Ocular Disease Associated with Rheumatoid Arthritis in the Biologic Era.
    Caimmi C; Crowson CS; Smith WM; Matteson EL; Makol A
    J Rheumatol; 2018 May; 45(5):595-603. PubMed ID: 29449499
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclophosphamide or Rituximab Treatment of Scleritis and Uveitis for Patients with Granulomatosis with Polyangiitis.
    Ahmed A; Foster CS
    Ophthalmic Res; 2019; 61(1):44-50. PubMed ID: 29635229
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recognition of posterior scleritis and its treatment with indomethacin.
    Rosenbaum JT; Robertson JE
    Retina; 1993; 13(1):17-21. PubMed ID: 8460274
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidemiology and Clinical Features of Uveitis from Urban Populations in South India.
    Sabhapandit S; Murthy SI; Singh VM; Gaitonde K; Gopal M; Marsonia K; Sajid S; Babu K
    Ocul Immunol Inflamm; 2017; 25(sup1):S39-S45. PubMed ID: 27782762
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Commentary: Pattern of uveitis in a tertiary eye care center of central India: Results of a prospective patient database over a period of two years.
    Das D; Biswas J; Bhattacharjee H
    Indian J Ophthalmol; 2020 Mar; 68(3):482-483. PubMed ID: 32057008
    [No Abstract]   [Full Text] [Related]  

  • 38. Antineutrophil cytoplasmic antibody in uveitis and scleritis.
    Mills RA; Weeramanthri TS; Hollingsworth PN; Cooper RL
    Aust N Z J Ophthalmol; 1991 Feb; 19(1):71-3. PubMed ID: 2039628
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of Uveitis and Scleritis in Necrobiotic Xanthogranuloma.
    Gonzales JA; Haemel A; Gross AJ; Acharya NR
    J Ocul Pharmacol Ther; 2017 May; 33(4):325-333. PubMed ID: 28394239
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders.
    Levy-Clarke G; Jabs DA; Read RW; Rosenbaum JT; Vitale A; Van Gelder RN
    Ophthalmology; 2014 Mar; 121(3):785-96.e3. PubMed ID: 24359625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.